MA26491A1 - Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant . - Google Patents

Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .

Info

Publication number: MA26491A1
Authority: MA; Morocco
Prior art keywords: inflammatory; pharmaceutical compositions; same; compositions containing; inhibitor compounds
Prior art date: 1997-05-05

Application number

MA25059A

Other languages

English (en)

Inventor

Marie Lundy Kristin

Paul Ricketts Anthony

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1998-05-04

Publication date

2004-12-20

1998-05-04 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26491A1 publication Critical patent/MA26491A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

MA25059A 1997-05-05 1998-05-04 Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant . MA26491A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
MA26491A1 true MA26491A1 (fr)	2004-12-20

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25059A MA26491A1 (fr)	1997-05-05	1998-05-04	Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (fr)
JP (1)	JP2000513020A (fr)
KR (2)	KR20010012300A (fr)
CN (1)	CN1255059A (fr)
AP (1)	AP9801234A0 (fr)
AR (2)	AR011726A1 (fr)
AU (1)	AU6932198A (fr)
BG (1)	BG103852A (fr)
BR (1)	BR9808720A (fr)
CA (1)	CA2288759A1 (fr)
DZ (1)	DZ2479A1 (fr)
EA (1)	EA003696B1 (fr)
GT (1)	GT199800063A (fr)
HR (1)	HRP980244A2 (fr)
HU (1)	HUP0001286A3 (fr)
ID (1)	ID21311A (fr)
IL (1)	IL132570A0 (fr)
IS (1)	IS5220A (fr)
MA (1)	MA26491A1 (fr)
NO (1)	NO995389L (fr)
NZ (1)	NZ500183A (fr)
OA (1)	OA11213A (fr)
PA (1)	PA8450601A1 (fr)
PE (1)	PE72599A1 (fr)
PL (1)	PL337003A1 (fr)
SK (1)	SK148199A3 (fr)
TN (1)	TNSN98059A1 (fr)
TW (1)	TW590773B (fr)
UY (1)	UY24989A1 (fr)
WO (1)	WO1998050033A1 (fr)
YU (1)	YU55899A (fr)
ZA (1)	ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) *	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (fr) *	1998-10-23	2001-08-16	Merck Frosst Canada & Co.	Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
EP1637137A3 (fr) *	1999-03-10	2006-07-05	G.D. Searle LLC	Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux
WO2001034204A1 (fr) *	1999-11-11	2001-05-17	Eli Lilly And Company	Produits composes oncolytiques destines au traitement du cancer
US20020016342A1 (en) *	2000-05-15	2002-02-07	Edward Scolnick	Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
US6924303B2 (en)	2000-06-13	2005-08-02	Wyeth	Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2422803A1 (fr)	2000-08-07	2002-02-14	Vanderbilt University	Detection de l'activite cox-2 et des metabolites d'anandamide
US20040209959A1 (en) *	2001-07-16	2004-10-21	Edward Hogestatt	Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PL2266585T3 (pl)	2003-05-07	2013-10-31	Osteologix As	Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości
EP1651210A1 (fr) *	2003-07-31	2006-05-03	Pharmacia & Upjohn Company LLC	Formulation dispersable d'un agent anti-inflammatoire
US20080269310A1 (en) *	2005-05-20	2008-10-30	Adrian Paul Foster	Synergistic Combinations
CA2683415C (fr)	2007-04-04	2020-12-08	Sigmoid Pharma Limited	Composition pharmaceutique orale
WO2008132707A1 (fr)	2007-04-26	2008-11-06	Sigmoid Pharma Limited	Fabrication de minicapsules multiples
JP5640079B2 (ja)	2009-05-18	2014-12-10	シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄＰｈａｒｍａＬｉｍｉｔｅｄ	油滴含有組成物
BR112012002963A2 (pt)	2009-08-12	2017-10-24	Sigmoid Pharma Ltd	composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
ES2907285T3 (es) *	2014-03-06	2022-04-22	Elanco Animal Health Incorporated	Composiciones de grapiprant y procedimientos de uso de las mismas
EA036036B1 (ru)	2014-11-07	2020-09-16	Сигмойд Фарма Лимитед	Композиции, содержащие циклоспорин
EP3242557A4 (fr) *	2015-01-09	2018-09-05	Jaguar Health, Inc.	Méthodes de traitement de la diarrhée chez des animaux de compagnie
JP2023520367A (ja) *	2020-03-25	2023-05-17	エスアールアイインターナショナル	リポキシゲナーゼ阻害剤
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (fr) *	1987-02-03	1993-07-06	Alberto Ferro	Solutions de micelles mixtes

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/fr active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/fr not_active Withdrawn
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/fr not_active Ceased
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Ceased
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 CA CA002288759A patent/CA2288759A1/fr not_active Abandoned
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Ceased
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
EP0988034A1 (fr)	2000-03-29
TW590773B (en)	2004-06-11
EA003696B1 (ru)	2003-08-28
EA199900895A1 (ru)	2000-06-26
OA11213A (en)	2003-07-14
BG103852A (en)	2000-06-30
WO1998050033A1 (fr)	1998-11-12
IL132570A0 (en)	2001-03-19
CA2288759A1 (fr)	1998-11-12
PE72599A1 (es)	1999-08-12
AR039628A2 (es)	2005-03-02
UY24989A1 (es)	2001-10-25
HRP980244A2 (en)	1999-02-28
NZ500183A (en)	2002-04-26
AR011726A1 (es)	2000-08-30
SK148199A3 (en)	2001-09-11
AU6932198A (en)	1998-11-27
ID21311A (id)	1999-05-20
ZA983722B (en)	1999-11-04
TNSN98059A1 (fr)	2005-03-15
AP9801234A0 (en)	1999-11-04
BR9808720A (pt)	2000-07-11
CN1255059A (zh)	2000-05-31
IS5220A (is)	1999-10-19
PA8450601A1 (es)	2000-05-24
KR20040004406A (ko)	2004-01-13
KR20010012300A (ko)	2001-02-15
HUP0001286A3 (en)	2000-12-28
DZ2479A1 (fr)	2003-02-01
JP2000513020A (ja)	2000-10-03
NO995389D0 (no)	1999-11-04
NO995389L (no)	2000-01-04
HUP0001286A2 (hu)	2000-11-28
PL337003A1 (en)	2000-07-31
YU55899A (sh)	2003-08-29
GT199800063A (es)	1999-10-26

Publication	Publication Date	Title
MA26491A1 (fr)	2004-12-20	Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
MA26548A1 (fr)	2004-12-20	Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DZ3191A1 (fr)	2001-01-11	Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
BR9710372B1 (pt)	2013-02-05	composto, e, composiÇço farmacÊutica.
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
BR9805993B1 (pt)	2009-05-05	composição farmacêutica de aerossol.
MA26537A1 (fr)	2004-12-20	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
FR2732967B1 (fr)	1997-07-04	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
DZ2686A1 (fr)	2003-03-29	Formulation pharmaceutique orale à libération pulsée.
FR2705566B1 (fr)	1996-04-05	Nouvelles compositions pharmaceutiques.
DZ1916A1 (fr)	2002-02-17	Composés nouveaux et compostions pharmaceutiques les contenant.
BRPI9810519B1 (pt)	2012-02-22	derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
NO20003254L (no)	2000-08-21	Anti-østrogeniske steroider og farmasøytisk preparat inneholdende samme, samt anvendelse derav
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
MA26673A1 (fr)	2004-12-20	Composes pharmaceutiques
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
AU7294098A (en)	1998-11-27	Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
PT1112266E (pt)	2003-09-30	4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
BR9911871B1 (pt)	2010-10-19	derivados de ácido fenoxiacético e composições farmacêuticas contendo os mesmos.
MA26486A1 (fr)	2004-12-20	Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
MA26460A1 (fr)	2004-12-20	Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent.